Natalizumab Temporary Discontinuation Study
Clinical trial NCT02775110 · COMPLETED
Trial details
- NCT number
- NCT02775110
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.